💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadExplore for free

Earnings call: Medical Facilities Corp reports solid Q2 growth

Published 2024-08-07, 11:12 a/m
© Reuters.
MFCSF
-

Medical Facilities Corporation (OTC: OTC:MFCSF), a leading healthcare service provider, has reported a positive second quarter for 2024, with higher surgical and pain management case volumes contributing to a 2.4% increase in facility service revenue.

During the earnings call, President and CEO Jason Redman, accompanied by CFO David Watson, highlighted the company's financial achievements and operational progress, including the expansion of services at the Black Hills (NYSE:BKH) facility and the reduction of corporate debt.

Key Takeaways

  • Facility service revenue increased by 2.4% to $107.2 million.
  • Income from operations and EBITDA rose by 21% and 13.7%, respectively.
  • Black Hills facility to open a new heart and vascular institute.
  • Corporate credit facility reduced by $5 million; share repurchases totaled $3.9 million.
  • $6.9 million in PPP loans forgiven, to be recorded as government stimulus income.

Company Outlook

  • The company is optimistic about meeting the rising demand for quality heart and vascular care with the new Black Hills Heart & Vascular Institute.
  • MFC plans to continue reducing corporate debt and returning capital to shareholders through dividends and share repurchases.

Bearish Highlights

  • Inpatient cases saw a decline of 21.7%.
  • Consolidated net working capital and cash equivalents decreased compared to year-end.

Bullish Highlights

  • Surgical cases increased by 2.8%, with outpatient cases up by 6.1%.
  • Pain management cases rose by 2.2%.
  • Total operating expenses declined by 0.9%, with consolidated drugs and supplies down by 3.6%.

Misses

  • Despite overall growth, inpatient cases decreased significantly by 21.7%.
  • Net working capital and cash equivalents showed a reduction from the previous year-end.

Q&A Highlights

  • Sioux Falls hospital reported a revenue increase of 9%, driven by higher acuity spine and ENT procedures.
  • Oklahoma hospital underperformed, with a shift toward outpatient over inpatient cases.
  • Management addressed potential acquisition interest, noting the Board's obligation to consider any opportunities.
  • The range of services at Black Hills Heart & Vascular Institute will evolve, initially focusing on cardiovascular and vein procedures.

The company's ticker (DR.TO) and name (Medical Facilities Corporation) were mentioned as part of the earnings call, reflecting a commitment to transparency and shareholder communication. The call concluded with a look forward to the next quarter's update, leaving investors with a cautiously optimistic view of MFC's trajectory.

InvestingPro Insights

Medical Facilities Corporation (MFC) has shown a robust performance in the second quarter of 2024, and recent data from InvestingPro provides additional insights into the company's financial health. Notably, MFC's management has been proactive in enhancing shareholder value, as reflected in the aggressive share buyback strategy. This aligns with the company's commitment to returning capital to shareholders, as mentioned in the article.

InvestingPro Data metrics reveal a market capitalization of $236.35 million, indicating the company's size and market presence. With a price-to-earnings (P/E) ratio of 19.92, and an adjusted P/E ratio for the last twelve months as of Q1 2024 at 15.73, MFC is trading at a valuation that suggests affordability relative to its earnings growth. Moreover, the company's PEG ratio during the same period stands at a mere 0.13, hinting at potential undervaluation when considering its earnings growth trajectory.

An InvestingPro Tip that stands out is the company's high shareholder yield, which is a comprehensive measure of the return shareholders are receiving from dividends and share repurchases. The tip is particularly relevant for investors focused on income and capital return.

Investors looking for more detailed analysis and additional InvestingPro Tips can find them on the InvestingPro platform. The platform includes a total of 12 tips for MFC, which provide a deeper dive into the company's performance and potential investment value.

In summary, the data and tips from InvestingPro underscore MFC's commitment to shareholder returns and present a picture of a company that is not only managing its operations effectively but also appears to be an attractive investment from a valuation standpoint.

Full transcript - Medical Facilities Corp (MFCSF) Q2 2024:

Operator: Good morning, everyone. Welcome to Medical Facilities Corporation’s 2024 Second Quarter Earnings Call. [Operator Instructions] Before turning the call over to management, listeners are reminded that today’s call may contain forward-looking statements with the meaning of the Safe Harbor provisions of Canadian provincial securities laws. Forward-looking statements involve risks and uncertainties and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. For additional information, please consult the MD&A for this quarter, the Risk Factors section of the annual information form and Medical Facilities’ other filings with Canadian securities regulators. Medical Facilities does not undertake to update any forward-looking statements. Such statements speak only as of the date made. I would now like to turn the meeting over to Mr. Jason Redman, President and CEO of Medical Facilities. Please go ahead, Mr. Redman.

Jason Redman: Thank you, operator, and good morning, everyone. With me on the call is our Chief Financial Officer, David Watson. Earlier this morning, we reported our second quarter results. Our news release, financial statements and MD&A are available on our website and have been filed on SEDAR+. Please note that the income statement variance as discussed by Dave and I this morning will exclude the results from the divested MFC Nueterra ASCs and non-controllable non-cash corporate level charges related to share-based compensation plans. Overall, our hospitals continue to perform well in the quarter, benefiting from higher surgical and pain management case volumes as well as favorable case in payer mixes. These factors resulted in a 2.4% increase in facility service revenue and combined with savings at the corporate level, helped drive a 21% increase in income from operations and a 13.7% increased EBITDA. While on the topic of our hospitals back in early June, we announced that our Black Hills facility will expand its services to include heart and vascular care with the opening of the Black Hills Heart & Vascular Institute. Institute will provide a comprehensive range of services from preventive care to interventional cardiac, vascular and vein procedures. To support the Institute, Black Hills plans to build a state-of-the-art cardiac catheterization lab for advanced cardiac and coronary procedures. The clinical lab will be situated next to Black Hills Surgical Hospital. MFC is excited to partner with Black Hills team to meet the increasing demand for quality heart and vascular care in Rapid City and its surrounding areas. In addition to our solid financial results for the quarter, we made further progress in paying down corporate debt and repurchasing shares under a normal course issuer bid. In the quarter, we reduced our corporate credit facility by a further $5 million and returned another $3.9 million to shareholders through the purchase of 421,800 common shares under the NCIB. Subsequent to quarter end, we received favorable news regarding the U.S. Small Business Administration review of $6.9 million of the $12 million in Paycheck Protection Program loans issued to certain facilities during the pandemic. The SBA completed its review of these particular loans and confirmed full forgiveness. As a result, we will record the $6.9 million as government stimulus income in the third quarter and reversed a corresponding liability previously recorded under government stimulus funds repayable. For the $5.1 million in PPP loans that remain, we will continue to diligently pursue all reasonably available channels to reverse any remaining denials for the outstanding PPP loans. I would now like to turn the call over to David to review our financial results for the quarter. David?

David Watson: Thank you, Jason. Good morning, everyone. As usual, please note that all dollar amounts that follow are in U.S. dollars. Second quarter facility service revenue grew 2.4% to $107.2 million. The increase of $2.5 million was attributable to higher surgical and pain management case volumes as well as favorable case and payer mixes. Total surgical cases were up 2.8% as observation cases increased by 13.1%, and outpatient cases were 6.1% higher, but inpatient cases were down 21.7%. Pain management cases were up 2.2%. Total operating expenses declined 0.9% to $88.3 million with reductions in drugs and supplies and G&A expenses, mostly offset by the increase in salaries and benefits. Consolidated salaries and benefits increased 5.4%, primarily due to higher clinical and non-clinical salaries and wages as a result of annual merit increases, full-time equivalent increases and market wage pressures. This was partly offset by the impact of the sale of Black Hills Surgical Hospital [indiscernible] Urgent Care center during the quarter and cost-saving initiatives at the corporate level. Consolidated drugs and supplies decreased 3.6% due to a case mix that reflected lower acuity cases and improved cost savings at certain facilities. Consolidated G&A expenses were down 4.8% due to lower equipment rentals and purchases, lower physician guarantees, cost savings at the corporate level and the sale of the [indiscernible] Urgent Care Clinic in April. And as Jason highlighted earlier, EBITDA increased 13.7% to $23.8 million. Looking quickly at our balance sheet. At the end of the quarter, we had consolidated net working capital of $8.7 million and cash and cash equivalents of $18 million compared to net working capital of $19.8 million and cash and cash equivalents of $24.1 million at year-end. The reductions in net working capital and cash and cash equivalents are the result of the continuing return of capital to shareholders through dividends and share purchases under the NCIB program as well as further reductions in corporate debt. Through the first 6 months of the year, we have paid $3 million in dividends, reduced the outstanding balance of our corporate credit facility by a total of $10 million, including $5 million during the second quarter and returned $5.7 million to shareholders through the purchase of 675,700 common shares under the NCIB. This concludes our prepared remarks. We would now like to open up the call for questions. Operator?

Operator: Thank you. [Operator Instructions] Your first question comes from Douglas Miehm of RBC (TSX:RY) Capital Markets. Please go ahead. Your line is open.

Douglas Miehm: Hey, good morning. Thank you for taking my questions. First question just has to do with two specific hospitals. I guess Sioux Falls and Oklahoma. And Sioux Falls was exceptionally strong this quarter, up 9% overall in terms of revenues. And perhaps you can expand on the reason for that. And then maybe the same for Oklahoma, but the other way, considerably weaker than anticipated. I know that you talked about the combined impact and case in payer mix. But has got a move or a change that it could be sustained going forward? Or would you expect a rebound just based on quarterly pacing?

David Watson: Yes. Hey, Doug, so with respect to Sioux Falls, as we mentioned, they had higher surgical case volume. The mix was good. They saw more higher acuity spine cases. And that’s – as well as the ENT procedures. So overall, that’s what was driving that. They did have a strong – very strong quarter. On the opt [ph] side, they saw – a lot of it was case mix, so less on the inpatient, more on the outpatient side. However, I think that’s more of a quarterly and we’ll have to see how that goes.

Douglas Miehm: Okay. And then my other question is just, it sounds like one of your much larger competitors is on the block in it. I am curious about how you think about your business and hit wherever an opportunity for you to do the same thing or if the company were approached. Is there any way that the minority shareholders here are required to buy into any potential sale of the company, or is it completely up to current shareholders, management and the Board?

Jason Redman: Hi Doug, appreciate the question. I mean look, if there was an opportunity for a potential transaction, as you know, the Board has an obligation to consider that and we will do so accordingly. And that’s the decision that the Board and the current shareholders would have to make.

Douglas Miehm: And there is nothing that the doctor [Technical Difficulty] prevent from…?

Jason Redman: I think obviously, I mean anyone who is going to be interested in our assets would want the doctor support. And that’s the main revenue generator. So, I think they would want to be alignment on any transaction that would happen.

Douglas Miehm: Okay. That’s great. Okay. Thank you.

Jason Redman: Thanks Doug.

Operator: And your next question comes from Doug Loe of Leede Financial. Please go ahead. Your line is open.

Doug Loe: Yes. Thank you, operator and Jason, thanks for taking my call. Just kind of looking retrospectively back to your announcement on the opening of the Black Hills Heart & Vascular Institute. And I appreciate you gave a few general comments in that press release and in your MD&A this morning, on just what the breadth of services might be that you might offer within that new initiatives. I men it’s a pretty broad category. And you specifically mentioned catheterization, I assume you might do the ablation for heart arrhythmia. You mentioned vein procedures, which multiple varicose veins procedures that they are currently FDA approved. So, those are just two ideas that just kind of popped into my head, just kind of define the breadth of services that you might provide within that institute and whether that platform if sort of successful in the first few quarters might be expandable to you a few other hospitals. And I will leave it there. Thanks.

Jason Redman: Yes. So, thanks. I mean this right now is unique to Black Hills. If there is an opportunity for other areas, I mean we have stated that we are always going to be looking for ways to add service lines to our other facilities. But for now, it’s focused on the Black Hills area. I think the range of services will continue to evolve over time as these doctors, the three physicians get in place and start to build out their practice. We can see this evolving. But for now, it’s really what we have mentioned the cardiovascular and the vein procedures. That’s going to be the main focus. But we are – well, as I have said, we are building on the state-of-the-art cath lab in our facility to accommodate a range of different services.

Doug Loe: Okay. Fair enough. Thanks.

Operator: [Operator Instructions] And there are no further questions at this time. I would now like to turn the call back over to Mr. Redman for closing comments.

Jason Redman: Thank you, operator. I would like to thank everyone for joining us this morning. We look forward to updating you again next quarter.

Operator: Ladies and gentlemen, this concludes today’s conference. We thank you for participating and ask that you please disconnect your lines.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.